Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Breast 1

Conditions

Carcinoma, Lobular 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Molecular Diagnostic Techniques × Breast × Clear all
NCT00536718 2013-08-12

Genetics of Women With Lobular Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Unknown
3,000 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡